Strategies for detecting colon cancer in patients with inflammatory bowel disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 9, 2017, Pages

  Bye, William A ^a   Nguyen, Tran M ^b   Parker, Claire E ^b   Jairath, Vipul ^c   East, James E ^d  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERMETHOD COMPARISON; MORTALITY RATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL RATE; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; BIOPSY; COLON; COLON TUMOR; COMPLICATION; CROHN DISEASE; HEALTH SURVEY; MORTALITY; PATHOLOGY;

BIOPSY; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLONOSCOPY; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE;

EID: 85029549986     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000279.pub4     Document Type: Review

References (83)

1. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clinical Gastroenterology & Hepatology 2015;13(2):322-9. 6715567
2. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, et al. Colonoscopy is associated with a reduced risk of colon cancer and morality in patients with inflammatory bowel diseases. American Journal of Gastroenterology 2014;109:S639. 6715568
3. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105:418-24. 2823064
4. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998;42:711-4. 2823066
5. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. American Journal of Gastroenterology 1990;85(9):1083-7. 6715569
6. Lutgens MW, Oldenburg B, Siersema PD, van Bodegraven AA, Dijkstra G, Hommes DW, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. British Journal of Cancer 2009;101(10):1671-5. 6715571
7. Lutgens MW, Vleggaar FP, Schipper ME, Stokkers PC, van der Woude CJ, Hommes DW, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008;57(9):1246-51. 6715572
8. Akbar T, Rahmany S, Harris R, Cotton S, McCabe LA, Lloyd DA, et al. Colorectal cancer in inflammatory bowel disease-is surveillance working?. United European Gastroenterology Journal 2015;1:A626. 6715574
9. Arthurs E, Burley K, Gholkar B, Williams L, Lockett M. Colorectal cancer surveillance in inflammatory bowel disease: A retrospective audit of primary and secondary care. Journal of Crohn's and Colitis 2012;6:S139. 6715576
10. Basseri RJ, Basseri B, Vassilaki ME, Melmed GY, Ippoliti A, Vasiliauskas EA, et al. Colorectal cancer screening and surveillance in Crohn's colitis. Journal of Crohn's and Colitis 2012;6(8):824-9. 6715578
11. Biasco G, Rossini FP, Hakim R, Brandi G, Di Battista M, Di Febo G, et al. Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Digestive and Liver Disease 2002;34(5):339-42. 6715579
12. Bopanna S, Das P, Dattagupta S, Pratap Mouli V, Kedia S, Dhingra R, et al. High incidence of ulcerative colitis related colorectal cancer in a low incidence area of sporadic colon cancer. Gastroenterology 2016;1:S765. 6715581
13. Brostrom O, Lofberg R, Ost A, Reichard H. Cancer surveillance of patients with longstanding ulcerative colitis: A clinical, endoscopical, and histological study. Gut 1986;27(12):1408-13. 6715583
14. Carballal S, Lopez-Ceron M, Ricart E, De Miguel CR, Cuatrecasas M, Romero I, et al. Results of a chromoendoscopy-based surveillance program for long-standing colonic inflammatory bowel disease. Gastrointestinal Endoscopy 2014;1:AB464. 6715585
15. Choi CH, Rutter M, Askari A, Lee GH, Warusavitarne J, Moorghen M, et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: An updated overview. American Journal of Gastroenterology 2015;110:1022-34. 6715587
16. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Alimentary Pharmacology & Therapeutics 2000;14:145-53. 6715588
17. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 2001;120:820-6. 6715589
18. Gonzalez R, Pereyra L, Gomez EJ, Mella JM, Omodeno M, Panigadi N, et al. Neoplasia Detection During Colonoscopic Surveillance of Patients With Inflammatory Bowel Disease: Does the Endoscopist's and Endoscopie's Characteristics Matter?. Gastrointestinal Endoscopy 2016;1:AB291. 6715591
19. Gunther U, Kusch D, Heller F, Burgel N, Leonhardt S, Daum S, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: Comparison of random biopsy vs. targeted biopsy protocols. International Journal of Colorectal Disease 2011;26(5):667-72. 6715593
20. Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. British Journal of Cancer 2003;89(7):1232-6. 6715594
21. Hernandez N, Penate M, Saiz P, Monescillo A, Jimenez E, Sanchez MA, et al. Dysplasia and colorectal cancer in surveillance colonoscopies of ulcerative colitis in a single center: Retrospective study. Journal of Crohn's and Colitis 2013;7:S112. 6715596
22. Higashi D, Futami K, Ishibashi Y, Egawa Y, Maekawa T, Matsui T, et al. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Research 2011;31(7):2499-504. 6715598
23. Hiroyuki A, Shinsuke K, Takashi N, Toshiaki T, Junichiro T, Tomomichi K, et al. Effectiveness of 34-year surveillance colonoscopy program for long-standing ulcerative colitis in a single institution. Inflammatory Bowel Diseases 2014;20:S42. 6715600
24. Jonsson B, Ahsgren L, Andersson LO, Stenling R, Rutegard J. Colorectal cancer surveillance in patients with ulcerative colitis. British Journal of Surgery 1994;81:689-91. 6715601
25. Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 Years' experience in a patient cohort from a defined population area. Scandinavian Journal of Gastroenterology 2005;40(9):1076-80. 6715603
26. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990;99:1021-31. 6715604
27. Lynch D, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34(8):1075-80. 6715606
28. Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyoty M, Nieminen I, et al. The risk of colorectal cancer in patients with inflammatory bowel disease in Finland: A follow-up of 20 years. Journal of Crohn's and Colitis 2013;7:551-7. 6715608
29. Matsuoka H, Ikeuchi H, Uchino M, Bando T, Takesue Y, Nishigami T, et al. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. International Journal of Colorectal Disease 2013;28:829-34. 6715610
30. Monzur F, Jennings J, Mattar M, Charabaty A. IBD-associated CRC: Are we screening often enough?. American Journal of Gastroenterology 2013;108:S501-2. 6715612
31. Mooiweer E, van der Meulen AE, van der Woude CJ. Incidence of interval colorectal cancer among inflammatory bowel disease patients enrolled in a colonoscopic surveillance program. Gastroenterology 2014;1:S632. 6715614
32. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8. 6715615
33. Panara AJ, Zhang HC, Waljee AK, Gaidos J, Feagins LA, Govani SM, et al. Presence of colonic dysplasia prior to colorectal cancer diagnosis is associated with early stage cancer among patients with inflammatory bowel disease: A national cohort study. Gastroenterology 2016;1:S561. 6715617
34. Riegler G, Bossa F, Caserta L, Pera A, Tonelli F, Sturniolo GC, et al. Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy: A retrospective co-operative IG-IBD study. Digestive and Liver Disease 2003;35:628-34. 6715619
35. Rodino S, D'Amico T, Sebkova L, Sacca N. Fifteen years colonoscopy surveillance for colorectal cancer in patients with inflammatory bowel disease: Efficacy of endoscopic polypectomy. Gastrointestinal Endoscopy 2011;1:AB439. 6715621
36. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6. 6715622
37. Rutegard M, Palmqvist R, Stenling R, Lindberg J, Rutegard J. Efficiency of Colorectal Cancer Surveillance in Patients With Ulcerative Colitis: 38 Years' Experience in a Patient Cohort From a Defined Population Area. Scandinavian Journal of Surgery 2016;18:18. 6715624
38. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis. Gastroenterology 2006;130(4):1030-8. 6715626
39. Saoula H, Boutaleb AF, Aissaoui M, Mahiou H, Salah A, Zmiri Y, et al. Screening for dysplasia and colorectal cancer in ulcerative colitis. United European Gastroenterology Journal 2013:A211. 6715628
40. Stolwijk JAM, Langers AMJ, Hardwick JC, Veenendaal RA, Verspaget HW, Van Hogezand RA, et al. A thirty-year follow-up surveillance study for neoplasia of a Dutch ulcerative colitis cohort. Scientific World Journal 2013:Article Number: 274715. 6715630
41. Velayos F, Loftus E, Jess T, Harmsen S, Bida J, Zinsmeister A, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006;130:1941-9. 6715632
42. Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356-62.
43. Baars JE, Kuipers EJ, Haastert M, Nicolai JJ, Poen AC, Van der Woude CJ. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. Journal of Gastroenterology 2012;47:1308-22.
44. Bansal P, Sonnenburg A. Risk factors of colorectal cancer in inflammatory bowel disease. American Journal of Gastroenterology 1996;91:44-8.
45. Bargen JA. Chronic ulcerative colitis associated with malignant disease. Archives of Surgery 1928;17(4):561-76.
46. Beaugeri L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. New England Journal of Medicine 2015;372(15):1441-52.
47. Blonksi W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?. Scandinavian Journal of Gastroenterology 2008;43:698-703.
48. Boberg KM, Lind GE. Primary sclerosing cholangitis and malignancy. Best Practice & Research. Clinical Gastroenterology 2011;25(6):753-64.
49. Boonstra K, Weersma RK, Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis. Hepatology 2013;58(6):2045-55.
50. Choi CR, Al BakirI, Hart AL, Graham TA. Clonal evolution of colorectal cancer in IBD. Nature Reviews Gastroenterology and Hepatology 2017;14(4):218-29.
51. Crohn BB, Rosenburg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Amercian Journal of Medical Science 1920;170:220-8.
52. Crohn BB, Rosenburg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). American Journal of the Medical Sciences 1925;170:220.
53. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
54. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. Journal of Pathology 2001;194:152-7.
55. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
56. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. New England Journal of Medicine 1990;323:1228-33.
57. Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. Journal of Clinical Pathology 2013;66(12):1005-26.
58. Fumery M, Dulai PS, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients with Ulcerative Colitis with Low-Grade Dysplasia: A systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2017;15(5):665-74.
59. Goldman H. Significance and detection of dysplasia in chronic colitis. Cancer 1996;789:2261-3.
60. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133(4):1099-105.
61. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
62. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflammatory Bowel Diseases 2006;12(5):S3-9.
63. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012;143(2):382-9.
64. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
65. Itzkowitz SH, Steven H, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology 2004;287(1):7-17.
66. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies. Clinical Gastroenterology and Hepatology 2012;10:639-45.
67. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology 2015;12:720-27.
68. Kisiel JB, Ahlquist DA. Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view. Therapeutic Advances in Gastroenterology 2013;6(5):371-80.
69. Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148(3):639-51.
70. Lashner BA. Colon cancer surveillance in ulcerative colitis. Seminars in Gastrointestinal Disease 1991;2:126-31.
71. Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflammatory Bowel Diseases 2013;19(4):789-99.
72. Magro R, Langer C, Driessen A, Ensari K, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. Journal of Crohns and Colitis 2013;7(10):827-51.
73. Odze RD, Goldblum J, Noffsinger A, Alsaigh N, Rybicki LA, Fogt F. Inter-observer variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Modern Pathology 2002;15:379-86.
74. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Human Pathology 1983;14:931-68.
75. Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointestinal Endoscopy 2004;60(3):334-9.
76. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from¬www.cochrane-handbook.org, 2011.
77. Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in inflammatory bowel disease. Gastrointestinal Endoscopy 2015;81(5):1101-21.
78. Söderlund S, Brandt L, Lapidus A, Karlén P, Broström O, Löfberg R, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009;136:1561-7.
79. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointestinal Endoscopy 2002;56(1):48-54.
80. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Alimentary Pharmacology & Therapeutics 2007;25(6):657-68.
81. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-16.
82. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 31 Aug 2017).
83. Collins P, Mpofu C, Watson A, Rhodes J. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD000279.pub3]